Schonfeld Strategic Advisors’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,565
| Closed | -$35.9K | – | 2192 |
|
|
2025
Q1 | $35.9K | Sell |
2,565
-2,470
| -49% | -$34.6K | ﹤0.01% | 1953 |
|
|
2024
Q4 | $83.7K | Sell |
5,035
-16,660
| -77% | -$277K | ﹤0.01% | 1783 |
|
|
2024
Q3 | $411K | Buy |
21,695
+18,690
| +622% | +$354K | ﹤0.01% | 1385 |
|
|
2024
Q2 | $43.5K | Buy |
+3,005
| New | +$43.5K | ﹤0.01% | 1811 |
|
|
2023
Q3 | – | Sell |
-11,113
| Closed | -$1.06M | – | 1909 |
|
|
2023
Q2 | $1.06M | Buy |
+11,113
| New | +$1.06M | 0.01% | 932 |
|
|
2021
Q3 | – | Sell |
-5,330
| Closed | -$2.54M | – | 2181 |
|
|
2021
Q2 | $2.54M | Buy |
+5,330
| New | +$2.54M | 0.03% | 612 |
|
|
2021
Q1 | – | Sell |
-723
| Closed | -$355K | – | 1943 |
|
|
2020
Q4 | $355K | Buy |
723
+123
| +21% | +$60.4K | ﹤0.01% | 1113 |
|
|
2020
Q3 | $339K | Buy |
+600
| New | +$339K | 0.01% | 1014 |
|